©2024 Stanford Medicine
Treating Tobacco Dependence in Inpatient Psychiatry - 1
Not Recruiting
Trial ID: NCT00136812
Purpose
The purpose of this study is to test in a randomized clinical trial a series of hypotheses
concerning the efficacy of an extended expert-system intervention plus nicotine replacement
therapy (NRT) for treating tobacco dependence among patients hospitalized on a smoke-free
psychiatric unit.
Official Title
Treating Tobacco Dependence in Inpatient Psychiatry
Stanford Investigator(s)
Judith Prochaska
Senior Associate Vice Provost, Clinical Research Governance and Professor of Medicine (Stanford Prevention Research Center)
Eligibility
Inclusion Criteria: Men and women over 18 years of age hospitalized on an inpatient
psychiatric unit who report smoking at least 5 cigarettes per day; smoking at least 100
cigarettes in one's lifetime, residing in the San Francisco Bay Area with no plan to
relocate outside of the area in the next 18 months, and access to a telephone for
scheduling follow up assessments.
Exclusion Criteria: Dementia or other brain injury precluding ability to participate;
non-English speaking; severe agitation, psychosis, or hostility; and medical
contraindications to nicotine replacement therapy (NRT). Recruitment of acutely psychotic,
manic, or hostile patients will be delayed until there is significant reduction of these
symptoms. Medical contraindications are: myocardial infarction in the preceding 3 months,
unstable angina pectoris, liver or kidney disease, current pregnancy or breast feeding,
allergies to adhesives, or other medical conditions that the medical team deems
incompatible with NRT use.
Intervention(s):
behavioral: stage-tailored intervention
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305